For example, in bladder cancer, lncRNAs such as TUG1 and SNHG1 have been implicated in modulating autophagy and contributing to therapy resistance through interactions with key signaling pathways like PI3K/Akt/mTOR and PP2A catalytic subunit, respectively. This evidence concerns the gene SNHG1 and urinary bladder cancer.